Gadofluorine M

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameGadofluorine M
Drug Alias NameResearch programme: MRI contrast agents - Bayer HealthCare Pharmaceuticalsgadofluorine 8gadofluorine-Pgadofluorine derivatives
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsNeoplasm Metastasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsNeoplasm Metastasis

Other Information

ATC CodeN/A
Related LinksN/A